Spuriously Low Fibrinogen Level with ACL Coagulometers in the Presence of a Translucent Clot

Thromb Haemost 1990; 63(02): 325
DOI: 10.1055/s-0038-1645221

Letters to the Editor

Schattauer GmbH Stuttgart

V Gufflet

Laboratoire Central d’Immunologie et d’Hématologie, Hôpital Saint-Antoine, Paris, France

,

C Crouzier

Laboratoire Central d’Immunologie et d’Hématologie, Hôpital Saint-Antoine, Paris, France

,

A Robert

Laboratoire Central d’Immunologie et d’Hématologie, Hôpital Saint-Antoine, Paris, France

References
1 Rossi E, Mondocino P, Lombardi A, Preda L. Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res 1988; 52: 453-468
2 Hoffmann JJ M L, Verhappen MA L. Automated nephelometry of fibrinogen: analytical performance and observations during thrombolytic therapy. Clin Chem 1988; 34: 2135-2140
3 Lackner H, Hunt V, Zucker MB, Pearson J. Abnormal fibrin ultrastructure, polymerization, and clot retraction in multiple myeloma. Br J Haematol 1970; 18: 625-636
4 Cohen I, Amir J, Ben-Shaul Y, Pick A, De Vries A. Plasma cell myeloma protein causing impairment of fibrin aggregation and platelet function in a patient with multiple malignancy. Am J Med 1970; 48: 766-776
5 Carrell N, Gabriel A, Blatt P, Carr M, McDonagh J. Hereditary dysfibrinogenemia in a patient with thrombotic disease. Blood 1983; 62: 439-447